Table 2 Risk factors for bacteremia relating to access type and patient status
From: Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review
Country | Risk factor | Relative risk bacteremia | Reference |
|---|---|---|---|
Canada | Prior access infection (vs. no prior access infection) | 3.33 (95 %CI 2.1–5.2) | [1] |
Canada | 30 days post-access type change (vs. continued HD modality) | 1.56 (95 %CI 1.02–2.4) | [1] |
Canada | Cuffed catheter (vs. AVF) | 8.49 (95 %CI 3.0–23.8) | [1] |
Canada | Uncuffed catheter (vs. AVF) | 9.87 (95 %CI 3.5–28.2) | [1] |
|  | Catheter vs. AV Graft | 7.6 (95 %CI 3.7–15.6) | [19] |
USA | Chronic HD vs. non-HD patients | 1.8 (95 %CI 1.1–3.1) | [2] |
France | Immunosuppressive therapy (vs. no immunosuppressive treatment) | 3.0 (95 %CI 1.0–6.1) | [19] |
France | Prior access infection (vs. no prior access infection) | 7.3 (95 %CI 3.2–16.4) | [19] |
Denmark | S. aureus bacteremia with CVC (vs. none); general inpatient population not specific to ESRD | 6.9 (95 %CI 2.8–17.0) | [20] |